GSK (LON:GSK) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

GSK plc (LON:GSK)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,440 ($18.59) and traded as high as GBX 1,522.50 ($19.66). GSK shares last traded at GBX 1,511 ($19.51), with a volume of 9,054,711 shares traded.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a research report on Tuesday, January 7th. Berenberg Bank lowered their price objective on GSK from GBX 1,820 ($23.50) to GBX 1,600 ($20.66) and set a “buy” rating on the stock in a research report on Friday, November 29th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, GSK presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,805.83 ($23.32).

GSK Stock Down 0.1 %

The company has a 50-day moving average price of GBX 1,441.42 and a 200 day moving average price of GBX 1,439. The firm has a market capitalization of £61.23 billion, a PE ratio of 24.38, a P/E/G ratio of 1.24 and a beta of 0.31. The company has a debt-to-equity ratio of 114.64, a current ratio of 0.81 and a quick ratio of 0.73.

GSK (LON:GSK) last posted its quarterly earnings results on Wednesday, February 5th. The company reported GBX 23.20 ($0.30) EPS for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. Analysts forecast that GSK plc will post 175.980975 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Wendy Becker acquired 536 shares of GSK stock in a transaction on Thursday, March 20th. The shares were bought at an average cost of GBX 1,515 ($19.56) per share, with a total value of £8,120.40 ($10,484.70). Also, insider Emma Walmsley sold 38,459 shares of the stock in a transaction on Monday, February 17th. The shares were sold at an average price of GBX 1,418 ($18.31), for a total transaction of £545,348.62 ($704,129.92). 1.61% of the stock is owned by company insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.